The Role of Lipoprotein(a) As a Biomarker to Assess Cardiovascular Risk

This publication is sponsored by Novartis AG.

This Clinical Practice Brief provides an overview of the genetic cardiovascular risk biomarker lipoprotein a (Lp[a]), as well as its importance as an independent risk factor for cardiovascular disease, the prevalence of elevated Lp(a) levels among the global population, and recommendations for lipid management.

Download PDF